In the KEGG analysis, hub driving genes were significantly enriched in the well-known cancer-related pathways, such as mTOR, MAPK, ErbB signaling pathways, cell cycle, and non-small cell lung cancer (Supplementary Figure S4B). This evidence concerns the gene EGFR and non-small cell lung carcinoma.